The National Institutes of Health (NIH) is offering a funding opportunity for research on bioethical issues related to the development and use of bionic and robotic devices, specifically through the R21 Clinical Trial Optional grant mechanism. This initiative invites exploratory applications that address ethical questions throughout the design, testing, and implementation phases of these technologies, with a focus on areas such as informed consent, participant representation, and equitable access. The total funding available is approximately $2 million, with individual applications capped at $275,000 over a two-year period, and submissions are due by January 26, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-23-005.html.